Is the addition of ECG gating to technetium-99m sestamibi SPET of value in the assessment of myocardial viability? An evaluation based on two-dimensional echocardiography following revascularization

European Journal of Nuclear Medicine

Volumn 23, Issue 10, 1996, Pages 1315-1322

  González, Patricio ^a,b   Massardo, Teresa ^a   Muñoz, Alejandra ^a   Jofré, Josefina ^a   Rivera, Alfredo ^a   Yovanovich, Jorge ^a   Maiers, Emilio ^a   Ayala, Francisco ^a   Humeres, Pamela ^a   Ramírez, Alfredo ^a   Arriagada, Marco ^a   Zavala, Aquiles ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Dipyridamole; Myocardial revascularization; Myocardial viability; Single photon emission tomography; Technetium 99m sestamibi

Indexed keywords

DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ANGIOPLASTY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIPYRIDAMOLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; PREDICTIVE VALUE OF TESTS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 10244255177     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01367586     Document Type: Article

References (27)

1. Iskandrian A, Heo J, Stanberry C. When is myocardial viability an important clinical issue?. J Nucl Med 1994; 35 Suppl: 4S-7S.
2. Hendel R. Single-photon imaging for the assessment of myocardial viability. J Nucl Med 1994; 35 Suppl: 23S-31S.
3. Bonow R, Dilsizian V. Thallium-201 and technetium-99m-sestamibin for assessing viable myocardium. J Nucl Med 1992; 33: 815-818.
4. Freeman I, Grunwald A, Hoory S, Bodenheimer M. Effect of coronary occlusion and myocardial viability on myocardial activity of technetium-99m-sestamibi. J Nucl Med 1991; 32: 292-298.
5. González P, Massardo T, Maiers E, et al. Tc-99m-sestamibi perfusion imaging to assess myocardial viability, compared to improvement on echocardiographic wall motion after revascularization. Eur J Nucl Med 1994; 21: S103.
6. Klein L, Garcia EV, DePuey G, et al. Reversibility bullseye: a new polar bullseye map to quantify reversibility of stress induced SPECT T1-201 myocardial perfusion defects [abstract). J Nucl Med 1987; 28: 642.
7. Massardo T, Gonzalez P, Yovanovich J, et al. Evaluación de revascularización coronaria: comparación entre perfusion con sestamibi Tc99m gatillado y ecografia-amrinona como predictores de viabilidad. Rev Med Chile 1994; 122: 1353-1361.
8. Sackett DL, Haynes RD, Guyatt GH, Tugwell PT. Clinical epidemiology. A basic science for clinical medicine, 2nd edn. Boston: Little Brown & Co, 1991.
9. Hosmer DW Jr, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, 1989.
10. Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978; 8: 283-298.
11. Altehoefer C, Vom Dahl J, Biedermabnn M, et al. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. J Nucl Med 1994; 35: 569-574.
12. 99mTc sestamibi. Circulation 1994; 89: 2552-2561.
13. Mannting F, Morgan-Mannting MG. Gated SPECT with technetium-99m-sestamibi for assessment of myocardial perfusion abnormalities. J Nucl Med 1993; 34: 601-608.
14. Avery P, Hudson N, Hubner P. Evaluation of changes in myocardial perfusion and function on exercise in patients with coronary artery disease by gated MIBI scintigraphy. Br Heart J 1993; 70: 22-26.
15. Chua T, Kiat H, Germano G, et al. Gated technetium-99m-sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol 1994; 23: 1107-1114.
16. Trischler MD, Niggel JB, Battle RW, Fairbank JT, Brown KA. Validation of global and segmental left ventricular contractile function using gated planat technetium-99m-sestamibi myocardial perfusion imaging. J Am Coll Cardiol 1994; 23: 141-145.
17. Cuocolo A, Pace L, Nicolai E, et al. Identification of viable myocardium by ECG-gated technetium-99m methoxyisobutylisonitrilc (MIBI) imaging: relation to thallium-201 reinjection. J Nucl Med 1994; 35: 153P.
18. Maurea S, Cuocolo A, Soricelli A, et al. Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med 1995; 36: 1945-1952.
19. Maurea S, Cuocolo A, Soricelli A, et al. Myocardial viability index in chronic coronary artery disease: technetium-99m-methoxyisobutylisonitrile redistribution. J Nucl Med 1995; 36: 1953-1960
20. Bisi G, Sciagra R, Santoro GM, Rossi V, Fazzini PF. Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recovery. J Nucl Med 1995; 36: 1994-2000.
21. Cuocolo A, Pace L, Ricciardelli B, et al. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. J Nucl Med 1992; 33: 505-511.
22. 18F)fluorodeoxyglucose. Circulation 1994; 89: 578-587.
23. Marzullo P, Sambucetti G, Parodi O. The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability. J Nucl Med 1992; 33: 1925-1930.
24. 18F]FDG assessed by PET. J Nucl Biol Med 1994; 38: 540-544.
25. Maublant JC, Citron B, Lipiecki J, et al. Rest technetium 99m-sestamibi tomoscintigraphy in hibernating myocardium. Am Heart J 1995; 129: 306-314.
26. Soufer R, Dey HM, Ng C, Zaret B. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability. Am J Cardiol 1995; 75: 1214-1219.
27. Corbett JR, McGhie AI, Faber TL. Perfusion defect size and severity using gated sestamibi: comparison to ungated imaging. J Nucl Med 1994; 35: 155P.